5q09
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-[4-bromo-6-(carbamoylamino)pyridin-2-yl]-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea== | |
| - | + | <StructureSection load='5q09' size='340' side='right' caption='[[5q09]], [[Resolution|resolution]] 1.90Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5q09]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5Q09 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5Q09 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=96A:N-{[4-bromo-6-(carbamoylamino)pyridin-2-yl]carbamoyl}-5-(2-methoxyethyl)-4-methylthiophene-2-sulfonamide'>96A</scene></td></tr> | |
| - | [[Category: | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Fructose-bisphosphatase Fructose-bisphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.11 3.1.3.11] </span></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5q09 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5q09 OCA], [http://pdbe.org/5q09 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5q09 RCSB], [http://www.ebi.ac.uk/pdbsum/5q09 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5q09 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Fructose-bisphosphatase]] | ||
| + | [[Category: Alker, A]] | ||
| + | [[Category: Banner, D]] | ||
| + | [[Category: Benz, J]] | ||
| + | [[Category: Burley, S K]] | ||
| + | [[Category: Joseph, C]] | ||
| + | [[Category: Kuhn, B]] | ||
[[Category: Rudolph, M]] | [[Category: Rudolph, M]] | ||
[[Category: Ruf, A]] | [[Category: Ruf, A]] | ||
| - | [[Category: | + | [[Category: Shao, C]] |
| + | [[Category: Tetaz, T]] | ||
[[Category: Yang, H]] | [[Category: Yang, H]] | ||
| - | [[Category: | + | [[Category: D3r docking]] |
| - | [[Category: | + | [[Category: Hydrolase-hydrolase inhibitor complex]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 06:33, 9 January 2019
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-[4-bromo-6-(carbamoylamino)pyridin-2-yl]-3-[5-(2-methoxyethyl)-4-methylthiophen-2-yl]sulfonylurea
| |||||||||||
